Price T Rowe Associates Inc Blueprint Medicines Corp Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 6,250,823 shares of BPMC stock, worth $674 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,250,823

Previous 5,428,955 15.14%

Holding current value

$674 Million

Previous $501 Million 18.41%

% of portfolio

0.07%

Previous 0.07%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $60.1 Million - $82 Million	821,868 Added 15.14%	6,250,823 $593 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $2.97 Million - $6.28 Million	-67,622 Reduced 1.23%	5,428,955 $501 Million
Q3 2023 Nov 14, 2023	SELL	$46.9 - $66.0 $5.95 Million - $8.37 Million	-126,799 Reduced 2.25%	5,496,577 $276 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $28.5 Million - $44.8 Million	674,942 Added 13.64%	5,623,376 $355 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $24.6 Million - $32.5 Million	649,144 Added 15.1%	4,948,434 $223 Million

Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $11 Million - $17.8 Million	267,479 Added 6.63%	4,299,290 $188 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $79.9 Million - $124 Million	-1,599,876 Reduced 28.41%	4,031,811 $266 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $31.6 Million - $49 Million	698,562 Added 14.16%	5,631,687 $284 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $20.7 Million - $42.1 Million	382,586 Added 8.41%	4,933,125 $315 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $16.8 Million - $20.7 Million	178,711 Added 4.09%	4,550,539 $487 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $8.88 Million - $12 Million	109,714 Added 2.57%	4,371,828 $449 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $17.6 Million - $21.5 Million	212,840 Added 5.26%	4,262,114 $375 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $32.8 Million - $39.1 Million	361,508 Added 9.8%	4,049,274 $394 Million
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $340 Million - $459 Million	3,687,766 New	3,687,766 $414 Million

Others Institutions Holding BPMC

# of Institutions

313

Shares Held

60.6M

Call Options Held

634K

Put Options Held

691K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.44B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Blueprint Medicines Corp Transaction History